Article Information
- Received July 12, 2016
- Accepted July 14, 2016
- Published online July 21, 2016.
Author Information
- 1Département de Médecine Translationnelle et Neurogénétique, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale U-964, CNRS UMR-7104, Université de Strasbourg, 67400 Illkirch-Graffenstaden, France
- 2Laboratory of Neurophysiology, ULB Neuroscience Institute, Université Libre de Bruxelles, 1070 Brussels, Belgium
- 3Department of Psychiatry, Faculty of Medicine, Douglas Research Center, McGill University, Montréal, Québec H4H 1R3, Canada
- Correspondence should be addressed to Brigitte L. Kieffer, Douglas Hospital Research Center, Perry Pavilion Room E-3317.1, 6875 Boulevard LaSalle, Montréal, QC H4H 1R3, Canada. E-mail: brigitte.kieffer{at}douglas.mcgill.ca.
Author contributions
Author contributions: A.C.M. and B.L.K. designed research; A.C.M. and A.R. performed research; A.d.K.d.’E. contributed unpublished reagents/analytic tools; A.C.M. and A.R. analyzed data; A.C.M. and B.L.K. wrote the paper;.
Disclosures
The authors declare no competing financial interests.
This work was supported by the CNRS, Institut National de la Santé et de la Recherche Médicale, and Université de Strasbourg; by National Institutes of Health Grants 16658 (from the National Institute on Alcohol Abuse and Alcoholism) and 005010 (from the National Institute on Drug Abuse); Fonds de la Recherche Scientifique–Fonds de la Recherche Scientifique [F.R.S.–F.N.R.S. (Belgium); to A.d.K.d.’E.]; and Action de Recherche Concertée (to A.d.K.d.’E.). A.C.M. received Doctoral Fellowship FDT20140930830 from Fondation Française pour la Recherche Médicale, and is a Senior Research Associate of the F.R.S.–F.N.R.S. (Belgium) and a WELBIO investigator.
Funding
National Institute of Health
NIH-NIAAA #16658National Institute of Health
NIH-NIDA #005010
Other Version
- You are viewing the most recent version of this article.
- previous version (July 21, 2016).